N/A N=81 Ultrasound vs Palpation for Infant Lumbar Puncture
Spinal; Puncture, Complications
Primary: Lumbar Puncture Success - Composite Score Including Lab Results and Reported Attempts — 18; 19 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=55 Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)
Columnar Cell Variant Thyroid Gland Papillary Carcinoma · Follicular Variant Thyroid Gland Papillary Carcinoma · Metastatic Thyroid Gland Follicular Carcinoma
Primary: Complete Response Rate (Cohort 1) — 0 percentage of participants
N/A N=30 Performance and Safety of Biology-Guided Radiotherapy Using the RefleXion Medical Radiotherapy System (BIOGUIDE-X)
Cancer · Tumor, Solid · Cancer, Lung
Primary: Cohort I Recommended RefleXion FDG Dose (RRFD) to Enable the Use of BgRT Planning. — 6 Participants
Phase 3 N=519 Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
Colonoscopy
Primary: Proportion of Subjects With Successful Bowel Preparation — 215; 212 Participants — p=<0.001
N/A N=25 Study of Gemini Rechargeable Spinal Cord Stimulation (SCS) System
Chronic Pain
Primary: Confirmatory Safety Endpoint: The Rate of Serious Adverse Events Related to the Investigational IPG and/or Charging System — 0 Participants
Phase 2 N=47 A Clinical Trial of Durvalumab (MEDI4736) as 1st Line Therapy in Advanced Non-small Cell Lung Cancer Patients
Non-Small Cell Lung Cancer NSCLC
Primary: Overall Survival (OS) — 6.00 months
N/A N=197 A Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Dentifrice in the Relief of Dentinal Hypersensitivity in a Chinese Population
Dentin Sensitivity
Primary: Change From Baseline in Schiff Sensitivity Score at Week 8 (Test Dentifrice Versus [vs.] Negative Control) — -0.98; -1.14 Score on a scale — p=0.2639
Phase 4 N=40 An Open-Label Preference Evaluation of BLI800
Colonoscopy
Primary: Ease of Preparation Consumption — 3; 5; 15; 7 Participants
N/A N=100 Pathway to Detection & Differentiation of Delirium & Dementia in the Emergency Department
Cognitive Impairment · Emergency Care · Dementia
Primary: Percentage of Patients With Confirmed Delirium or Dementia — 30.8 percentage of participants
N/A N=162 Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds
Skin Wrinkling
Primary: Mean Change From Baseline in Wrinkle Severity Rating Scale (WSRS) at Week 24 After Final Initial Injection — -1.1; -1.1 Score on a scale
Phase 3 N=244 A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)
Parkinson's Disease (PD)
Primary: Number of Participants With Adverse Events — 121; 109; 230; 32 Participants
N/A N=80 InTSHA: Interactive Transition Support for HIV-infected Adolescents Using Social Media
HIV-1-infection · Adolescent Behavior
Primary: Acceptability of Intervention Measure Score — 4.1 score on a scale
Phase 1 N=32 First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent
Healthy
Primary: Pharmacokinetic (PK) Parameter Cmax — 264; 685; 992; 1960 nmol/mL
Phase 3 N=260 A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye
Dry Eye
Primary: Change From Baseline in Central Corneal Staining Score (CCSS) at Day 57 — 2.40; 2.37; -0.82; -0.79 score on a scale — p=0.764
Phase 3 N=919 Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Compensated Cirrhosis · Nonalcoholic Steatohepatitis
Primary: DB Phase: Number of Participants Who Were Responders and Showed Improvement in Fibrosis by at Least 1 Stage Without Worsening of Nonalcoholic Steatohepatitis (NASH)…